Myron Kaplan, Director at CorMedix Inc. (CRMD), bought 50,000 shares at $1.47 ($74K) on 2018-12-14, disclosed to the SEC on 2018-12-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CRMD | BUY | 2022-05-18 | $19K | — | Filing → |
| CRMD | BUY | 2021-11-19 | $51K | — | Filing → |
| CRMD | BUY | 2021-05-19 | $90K | — | Filing → |